In the underlying pilot study, we report elevated AH levels of ZAG, RBP-4, Reg-3a and elafin in patients with advanced NPDR/PDR in comparison to healthy controls, suggesting their involvement in the pathogenesis of DR and their potential use as biomarkers of late disease. Here, REG3A is linked to non-proliferative diabetic retinopathy.